Bellevue Group Ag Exact Sciences Corp Transaction History

Bellevue Group Ag

$5.93 Billion
Q3 2024

A detailed history of Bellevue Group Ag transactions in Exact Sciences Corp stock. As of the latest transaction made, Bellevue Group Ag holds 1,449,465 shares of EXAS stock, worth $71.5 Million. This represents 1.66% of its overall portfolio holdings.

Number of Shares

1,449,465

Previous 1,158,880 25.07%

Holding current value

$71.5 Million

Previous $49 Million 101.57%

% of portfolio

1.66%

Previous 0.82%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$42.43 - $70.83 $12.3 Million - $20.6 Million	290,585 Added 25.07%	1,449,465 $98.7 Million
Q2 2024 Aug 14, 2024	BUY	$41.33 - $74.26 $841,230 - $1.51 Million	20,354 Added 1.79%	1,158,880 $49 Million
Q1 2024 May 15, 2024	BUY	$56.27 - $73.77 $5.11 Million - $6.69 Million	90,740 Added 8.66%	1,138,526 $78.6 Million
Q4 2023 Feb 14, 2024	SELL	$59.06 - $75.72 $4.25 Million - $5.45 Million	-72,033 Reduced 6.43%	1,047,786 $77.5 Million
Q3 2023 Nov 14, 2023	BUY	$65.94 - $99.04 $7.45 Million - $11.2 Million	113,047 Added 11.23%	1,119,819 $76.4 Million
Q2 2023 Aug 14, 2023	SELL	$62.68 - $95.05 $13.7 Million - $20.7 Million	-218,270 Reduced 17.82%	1,006,772 $94.5 Million
Q1 2023 May 15, 2023	SELL	$47.19 - $70.77 $4.1 Million - $6.16 Million	-86,973 Reduced 6.63%	1,225,042 $83.1 Million
Q4 2022 Feb 14, 2023	BUY	$30.35 - $53.15 $5.53 Million - $9.69 Million	182,362 Added 16.14%	1,312,015 $65 Million
Q3 2022 Nov 14, 2022	BUY	$31.97 - $49.37 $11.9 Million - $18.3 Million	371,630 Added 49.03%	1,129,653 $36.7 Million
Q2 2022 Aug 11, 2022	BUY	$35.61 - $76.23 $1.38 Million - $2.95 Million	38,720 Added 5.38%	758,023 $29.9 Million
Q1 2022 May 13, 2022	BUY	$57.56 - $82.54 $4.42 Million - $6.33 Million	76,721 Added 11.94%	719,303 $50.3 Million
Q4 2021 Feb 10, 2022	BUY	$72.5 - $100.68 $15.5 Million - $21.5 Million	213,309 Added 49.69%	642,582 $50 Million
Q3 2021 Nov 12, 2021	BUY	$90.24 - $124.05 $13.9 Million - $19.1 Million	153,600 Added 55.72%	429,273 $41 Million
Q2 2021 Aug 12, 2021	BUY	$93.66 - $139.27 $5.39 Million - $8.01 Million	57,533 Added 26.37%	275,673 $34.3 Million
Q1 2021 May 12, 2021	BUY	$116.57 - $155.01 $2.7 Million - $3.59 Million	23,140 Added 11.87%	218,140 $28.7 Million
Q4 2020 Feb 16, 2021	SELL	$99.61 - $142.12 $10.9 Million - $15.6 Million	-109,490 Reduced 35.96%	195,000 $25.8 Million
Q3 2020 Nov 16, 2020	BUY	$72.92 - $102.01 $22.2 Million - $31.1 Million	304,490 New	304,490 $31 Million

Others Institutions Holding EXAS

# of Institutions

671

Shares Held

163M

Call Options Held

2.58M

Put Options Held

2.19M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $8.73B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.

Account

Bellevue Group Ag Exact Sciences Corp Transaction History